0001209191-15-010426.txt : 20150206
0001209191-15-010426.hdr.sgml : 20150206
20150206172239
ACCESSION NUMBER: 0001209191-15-010426
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20150129
FILED AS OF DATE: 20150206
DATE AS OF CHANGE: 20150206
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HCA Holdings, Inc.
CENTRAL INDEX KEY: 0000860730
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
IRS NUMBER: 273865930
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE PARK PLZ
CITY: NASHVILLE
STATE: TN
ZIP: 37203
BUSINESS PHONE: 6153449551
MAIL ADDRESS:
STREET 1: ONE PARK PLAZA
CITY: NASHVILLE
STATE: TN
ZIP: 37203
FORMER COMPANY:
FORMER CONFORMED NAME: HCA INC/TN
DATE OF NAME CHANGE: 20010627
FORMER COMPANY:
FORMER CONFORMED NAME: HCA THE HEALTHCARE CO
DATE OF NAME CHANGE: 20010419
FORMER COMPANY:
FORMER CONFORMED NAME: COLUMBIA HCA HEALTHCARE CORP
DATE OF NAME CHANGE: 20000502
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Englebright Jane D.
CENTRAL INDEX KEY: 0001632834
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11239
FILM NUMBER: 15585588
MAIL ADDRESS:
STREET 1: ONE PARK PLAZA
CITY: NASHVILLE
STATE: TN
ZIP: 37203
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2015-01-29
0
0000860730
HCA Holdings, Inc.
HCA
0001632834
Englebright Jane D.
ONE PARK PLAZA
NASHVILLE
TN
37203
0
1
0
0
SVP and Chief Nursing Officer
Common Stock
4553
D
Non-Qualified Stock Option (right to buy)
5.3074
2017-01-30
Common Stock
6608
D
Non-Qualified Stock Option (right to buy)
11.3208
2017-01-30
Common Stock
9892
D
Non-Qualified Stock Option (right to buy)
5.3074
2017-01-30
Common Stock
6608
D
Stock Appreciation Right
22.95
2022-02-08
Common Stock
5000
D
Stock Appreciation Right
22.95
2022-02-08
Common Stock
5000
D
Stock Appreciation Right
22.95
2022-02-08
Common Stock
5000
D
Stock Appreciation Right
37.18
2023-02-06
Common Stock
1750
D
Stock Appreciation Right
37.18
2014-02-06
2023-02-06
Common Stock
1750
D
Stock Appreciation Right
37.18
2023-02-06
Common Stock
5250
D
Stock Appreciation Right
47.97
2024-02-05
Common Stock
5500
D
Restricted Stock Units
2022-02-08
Common Stock
876
D
Restricted Stock Units
2023-02-06
Common Stock
1500
D
Restricted Stock Units
2024-02-05
Common Stock
1500
D
The option vested in two equal annual installments beginning on January 30, 2011.
The option vested at the end of fiscal years 2007, 2008 and 2009 based upon the achievement of certain annual EBITDA performance targets.
The option vested at the end of fiscal years 2010 and 2011 based upon the achievement of certain annual EBITDA performance targets.
On February 8, 2012, the reporting person was granted 10,000 stock appreciation rights. The stock appreciation rights are eligible to vest in equal increments of up to 25% at the end of fiscal years 2012, 2013, 2014 and 2015 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. EBITDA performance criteria for 2012 and 2013 was met, resulting in the vesting of 5,000 stock appreciation rights.
The stock appreciation rights vested in two equal annual installments beginning on February 8, 2013.
The stock appreciation rights vest in two equal annual installments beginning on February 8, 2015.
On February 6, 2013, the reporting person was granted 7,000 stock appreciation rights. The stock appreciation rights are eligible to vest in equal increments of up to 25% at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. EBITDA performance criteria for 2013 was met, resulting in the vesting of 1,750 stock appreciation rights.
The stock appreciation rights vest in three equal annual installments beginning on February 6, 2015.
The stock appreciation rights vest in four equal annual installments beginning on February 5, 2015.
The restricted stock units vest in two equal annual installments beginning February 8, 2015.
Each restricted stock unit represents a contingent right to receive one share of HCA Holdings, Inc. common stock.
The restricted stock units vest in three equal annual installments beginning February 6, 2015.
The restricted stock units vest in four equal annual installments beginning February 5, 2015.
/s/ Kevin A. Ball, Attorney-in-Fact
2015-02-06
EX-24.3_559294
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that the undersigned hereby makes,
constitutes and appoints John M. Franck II, Natalie Harrison Cline and Kevin A.
Ball as the undersigned's true and lawful attorneys-in-fact, with full power and
authority as hereinafter described on behalf of and in the name, place and stead
of the undersigned to:
(1) prepare, execute, acknowledge, deliver and file a Form ID (including any
amendments or authentications thereto) with respect to obtaining EDGAR codes,
with the U.S. Securities and Exchange Commission;
(2) prepare, execute, acknowledge, deliver and file Forms 3, 4 and 5 (including
any amendments thereto) with respect to the securities of HCA Holdings, Inc., a
Delaware corporation (the "Company"), with the U.S. Securities and Exchange
Commission, any national securities exchanges and the Company, as considered
necessary or advisable under Section 16(a) of the Securities Exchange Act of
1934 and the rules and regulations promulgated thereunder, as amended from time
to time (the "Exchange Act");
(3) seek or obtain, as the undersigned's representative and on the
undersigned's behalf, information on transactions in the Company's securities
from any third party, including brokers, employee benefit plan administrators
and trustees, and the undersigned hereby authorizes any such person to release
any such information to the undersigned and approves and ratifies any such
release of information; and
(4) perform any and all other acts which in the discretion of such
attorneys-in-fact are necessary or desirable for and on behalf of the
undersigned in connection with the foregoing.
The undersigned acknowledges that:
(1) this Power of Attorney authorizes, but does not require, such
attorneys-in-fact to act in their discretion on information provided to such
attorneys-in-fact without independent verification of such information;
(2) any documents prepared and/or executed by such attorneys-in-fact on behalf
of the undersigned pursuant to this Power of Attorney will be in such form and
will contain such information and disclosure as such attorney-in-fact, in his or
her discretion, deems necessary or desirable;
(3) neither the Company nor such attorneys-in-fact assumes (i) any liability
for the undersigned's responsibility to comply with the requirements of the
Exchange Act, (ii) any liability of the undersigned for any failure to comply
with such requirements, or (iii) any obligation or liability of the undersigned
for profit disgorgement under Section 16(b) of the Exchange Act; and
(4) this Power of Attorney does not relieve the undersigned from responsibility
for compliance with the undersigned's obligations under the Exchange Act,
including without limitation the reporting requirements under Section 16 of the
Exchange Act.
The undersigned hereby gives and grants the foregoing attorneys-in-fact full
power and authority to do and perform all and every act and thing whatsoever
requisite, necessary or appropriate to be done in and about the foregoing
matters as fully to all intents and purposes as the undersigned might or could
do if present, with full power of substitution and revocation, hereby ratifying
all that such attorney-in-fact, or such attorney-in-fact's substitute or
substitutes, of, for and on behalf of the undersigned, shall lawfully do or
cause to be done by virtue of this Power of Attorney.
This Power of Attorney shall remain in full force and effect until revoked by
the undersigned in a signed writing delivered to such attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 3rd day of February 2015.
/s/ Jane D. Englebright
Print Name: Jane D. Englebright